| Time | INDUSTRY SYMPOSIA |
|---|---|
| 2:45 PM – 3:30 PM | Bio-Rad
Can a droplet change a patient’s cancer treatment? ddPCR Industry Workshop |
| 2:45 PM – 3:30 PM | Invivoscribe, Inc.
NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies |
| 2:45 PM – 3:30 PM | NanoString Technologies
Validation of antibody panels for high-plex protein analysis on the GeoMx Digital Spatial Profiler |
| 3:30 PM – 3:45 PM | Break |
| 3:45 PM – 4:30 PM | BGI Americas
Advancement in precision cancer diagnostics for targeted and immunotherapies |
| 3:45 PM – 4:30 PM | Illumina, Inc.
How to further drive precision oncology by Comprehensive Genomic Profiling? |
| 3:45 PM – 4:30 PM | QIAGEN
Deconstructing the complexity: Tailored sample to insight tools that put your data into action |
| Time | INDUSTRY SYMPOSIA |
|---|---|
| 12:00 PM – 12:45 PM | Invivoscribe, Inc.
Monitoring Minimal Residual Disease (MRD) and Somatic Hypermutation (SHM) to Optimize Treatment of Hematologic Malignancies |
| 12:00 PM – 12:45 PM | Molecular Health
Scaling the anlyses and interpretation of NGS data with the medical device MH Guide in a clinical setting |
| 12:00 PM – 12:45 PM | Thermo Fisher Scientific
Powering Precision Oncology Through Next-Generation Sequencing |
| Time | INDUSTRY SYMPOSIA |
|---|---|
| 10:45 AM – 11:30 AM | SOPHiA GENETICS
Making Data Driven Medicine a reality: high precision in routine diagnostics using SOPHiA AI |
| 10:45 AM – 11:30 AM | SenseCare Medicals, Inc., USA, A Subsidiary of Urit, China
A Revolutionary Technology to Solve FFPE Sample Preparation Bottle-Neck Problem in Cancer Research and Diagnosis |
| 10:45 AM – 11:30 AM | AstraZeneca
East Meets West: Molecular testing in NSCLC to guide patient selection for targeted and immunotherapeutic agents (Sharing of regional molecular practices) |